Cargando…
Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial
Synthetic corticosteroids are widely used due to their anti-inflammatory and immunosuppressant effects. Their use has been associated with venous thromboembolism, but it is unknown whether thromboembolism has a causal relationship with corticosteroid treatment. In a randomised, double-blind, placebo...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377059/ https://www.ncbi.nlm.nih.gov/pubmed/37509691 http://dx.doi.org/10.3390/biomedicines11072052 |
_version_ | 1785079422795120640 |
---|---|
author | Kamstrup, Peter Rastoder, Ema Hellmann, Pernille Høgh Sivapalan, Pradeesh Larsen, Emil List Vestbo, Jørgen Ulrik, Charlotte Suppli Goetze, Jens P. Knop, Filip Krag Jensen, Jens Ulrik Stæhr |
author_facet | Kamstrup, Peter Rastoder, Ema Hellmann, Pernille Høgh Sivapalan, Pradeesh Larsen, Emil List Vestbo, Jørgen Ulrik, Charlotte Suppli Goetze, Jens P. Knop, Filip Krag Jensen, Jens Ulrik Stæhr |
author_sort | Kamstrup, Peter |
collection | PubMed |
description | Synthetic corticosteroids are widely used due to their anti-inflammatory and immunosuppressant effects. Their use has been associated with venous thromboembolism, but it is unknown whether thromboembolism has a causal relationship with corticosteroid treatment. In a randomised, double-blind, placebo-controlled trial in normal to overweight healthy men, the effect of the corticosteroid prednisolone on haemostasis using either 50 mg prednisolone or matching placebo once daily for ten days was investigated. The primary outcome was a change from baseline in the viscoelastic measurement maximal amplitude of clot in kaolin-activated thromboelastography (TEG). Changes from baseline in other TEG measurements, D-dimer, von Willebrand factor (VWF) antigen, and ristocetin cofactor activity (RCo), antithrombin, protein C, prothrombin, fibrinogen, INR, APTT, and platelet count were secondary outcomes. Thirty-four men participated in this study. Compared to placebo, prednisolone treatment did not affect maximal amplitude of clot (difference −0.77 (95% confidence interval (CI) −2.48, 0.94) mm, p = 0.37, missing: n = 2), but it altered VWF antigen (28%, p = 0.0004), VWF:RCo (19%, p = 0.0006), prothrombin (5%, p = 0.05), protein C (31%, p < 0.0001), antithrombin (5%, p = 0.013), and fibrinogen (−15%, p = 0.004). Thus, prednisolone treatment did not alter TEG-assessed maximal amplitude of clot, despite that it affected prothrombotic markers (increased prothrombin, VWF antigen, VWF:RCo, prothrombin, and decreased fibrinogen) and increased antithrombotic markers (protein C and antithrombin). |
format | Online Article Text |
id | pubmed-10377059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103770592023-07-29 Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial Kamstrup, Peter Rastoder, Ema Hellmann, Pernille Høgh Sivapalan, Pradeesh Larsen, Emil List Vestbo, Jørgen Ulrik, Charlotte Suppli Goetze, Jens P. Knop, Filip Krag Jensen, Jens Ulrik Stæhr Biomedicines Article Synthetic corticosteroids are widely used due to their anti-inflammatory and immunosuppressant effects. Their use has been associated with venous thromboembolism, but it is unknown whether thromboembolism has a causal relationship with corticosteroid treatment. In a randomised, double-blind, placebo-controlled trial in normal to overweight healthy men, the effect of the corticosteroid prednisolone on haemostasis using either 50 mg prednisolone or matching placebo once daily for ten days was investigated. The primary outcome was a change from baseline in the viscoelastic measurement maximal amplitude of clot in kaolin-activated thromboelastography (TEG). Changes from baseline in other TEG measurements, D-dimer, von Willebrand factor (VWF) antigen, and ristocetin cofactor activity (RCo), antithrombin, protein C, prothrombin, fibrinogen, INR, APTT, and platelet count were secondary outcomes. Thirty-four men participated in this study. Compared to placebo, prednisolone treatment did not affect maximal amplitude of clot (difference −0.77 (95% confidence interval (CI) −2.48, 0.94) mm, p = 0.37, missing: n = 2), but it altered VWF antigen (28%, p = 0.0004), VWF:RCo (19%, p = 0.0006), prothrombin (5%, p = 0.05), protein C (31%, p < 0.0001), antithrombin (5%, p = 0.013), and fibrinogen (−15%, p = 0.004). Thus, prednisolone treatment did not alter TEG-assessed maximal amplitude of clot, despite that it affected prothrombotic markers (increased prothrombin, VWF antigen, VWF:RCo, prothrombin, and decreased fibrinogen) and increased antithrombotic markers (protein C and antithrombin). MDPI 2023-07-21 /pmc/articles/PMC10377059/ /pubmed/37509691 http://dx.doi.org/10.3390/biomedicines11072052 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kamstrup, Peter Rastoder, Ema Hellmann, Pernille Høgh Sivapalan, Pradeesh Larsen, Emil List Vestbo, Jørgen Ulrik, Charlotte Suppli Goetze, Jens P. Knop, Filip Krag Jensen, Jens Ulrik Stæhr Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial |
title | Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial |
title_full | Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial |
title_fullStr | Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial |
title_full_unstemmed | Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial |
title_short | Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men—A Randomised Placebo-Controlled Trial |
title_sort | effect of 10-day treatment with 50 mg prednisolone once-daily on haemostasis in healthy men—a randomised placebo-controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377059/ https://www.ncbi.nlm.nih.gov/pubmed/37509691 http://dx.doi.org/10.3390/biomedicines11072052 |
work_keys_str_mv | AT kamstruppeter effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT rastoderema effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT hellmannpernillehøgh effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT sivapalanpradeesh effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT larsenemillist effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT vestbojørgen effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT ulrikcharlottesuppli effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT goetzejensp effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT knopfilipkrag effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial AT jensenjensulrikstæhr effectof10daytreatmentwith50mgprednisoloneoncedailyonhaemostasisinhealthymenarandomisedplacebocontrolledtrial |